Celgene Corporation (Celgene) is a biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases.
Celgene implements industry-leading human capital management policies with respect to its compensation practices, employee training offerings, and recruitment efforts. For example, the company’s remuneration practices include elements of variable pay and some stock plan offerings as well. Celgene also offers a range of educational and training programs for employees at various levels within the organization and has formal internship programs to further develop and retain its talent pool. Celgene also demonstrates above average supply chain management, holding its suppliers to a high standard through its Code of Conduct, and encouraging them to promote sustainable and responsible business practices to minimize environmental impact. In addition, Celgene has strong programs to boost access to health care for underserved communities. For example, the company has a data sharing policy that allows for the exchange of scientific information and has developed a number of capacity building efforts in emerging markets such as Kenya. Finally, Celgene has solid environmental accounting, which, in tandem with its long-term environmental goals, drives intensity reductions for the company and sets a precedent for its suppliers.
Celgene is subject to several governance concerns; several board directors serve on multiple other boards and its CEO and Chairman roles are not split. Separately, the company also lacks a formal responsible marketing and advertising policy.
Industry: Health Care
Country: United States
To the best of our knowledge the above information is accurate and was obtained from sources we believe to be reliable. Neither the information presented above nor any opinion expressed shall be construed as an offer to sell or a solicitation to buy the security. The views expressed are those of portfolio management as of 12/31/2016 and may not reflect current opinions or subsequent events.